Method AI

Method AI

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.methodsurgical.ai

Last Round

Series A

Aug 21, 2025

Total Funding Raised

$20M

Momentum Score

25 /100

Company Overview

Method AI is a medical technology company that is developing an AI-powered surgical navigation platform to improve outcomes in robotic-assisted oncology procedures. Spun out of the Cleveland Clinic in 2021, the company's platform utilizes continuous 3D ultrasound imaging and machine learning algorithms to create a real-time, 3D subsurface map of an organ during surgery. This technology provides surgeons with real-time guidance against an AI-generated surgical plan, aiming to visualize anatomy that is not visible to standard surgical cameras. The primary goal is to increase the rate of complete tumor removal, thereby improving cancer-free survival rates for patients. The company raised $20 million in a Series A funding round in August 2025. Its platform is currently under development and not yet cleared for commercial distribution.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Computer Vision, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

surgical intelligencesurgical video analysissurgical AIsurgical data platformsurgical performance analysisOR intelligencesurgical video managementsurgical computer visionFDA cleared AImedical AIsurgical educationclinical intelligencesurgical copilothealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Method AI Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Method AI Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 21, 2025

Key People

Founding team and executive leadership

Jihad Kaouk

Co-Founder Chief Medical Officer

Founding Team

Doug Teany

Co-Founder CEO

Founding Team

Per Bergman

Chief Technology Officer

Executive Team

Method AI Investors

Notable investors and investment history

InvestorRounds
JobsOhio VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2025

    $20M Series A round completed.

  • Aug 21, 2025

    Developing a surgical navigation platform with continuous 3D ultrasound imaging.

Method AI Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Method AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Method AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range12
Year Founded2021
Last FundingAug 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.